Načítá se...
Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities
Both type 1 and type 2 diabetes are associated with cardiac fibrosis that may reduce myocardial compliance, contribute to the pathogenesis of heart failure, and trigger arrhythmic events. Diabetes-associated fibrosis is mediated by activated cardiac fibroblasts, but may also involve fibrogenic actio...
Uloženo v:
| Vydáno v: | J Mol Cell Cardiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718740/ https://ncbi.nlm.nih.gov/pubmed/26705059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2015.12.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|